Earn points on every order · Free shipping on orders over $159 · New products in stock
Archive

Compound Category: Longevity and Bioregulators

BRONCHOGEN

A short peptide bioregulator (Khavinson) aimed at lung/bronchial tissue. The idea behind these tissue-specific bioregulators is to support the gene activity of a particular organ, here, the respiratory tract; in brief courses.

Read more →

Epithalon

Russian peptide that activates telomerase, the enzyme that keeps the ends of your chromosomes from fraying. The most-studied of the longevity peptides.

Read more →

HUMANIN

A peptide your mitochondria themselves encode, a cousin of MOTS-c. It protects cells from stress and death, supports metabolism, and is studied for neuroprotection and longevity. Levels fall with age.

Read more →

PINEALON

A short peptide bioregulator (Khavinson) aimed at the brain. Proposed to support cognition, neuroprotection, and healthy sleep/circadian regulation in brief courses; the brain-targeted member of the bioregulator family.

Read more →

PNC-27

An experimental anticancer peptide. In the lab it pokes holes in cancer-cell membranes (which display a protein called HDM-2) while sparing normal cells. Striking in a dish, but it has never been tested in humans, and the FDA has warned that PNC-27 products are unapproved with no established safety. This is a research compound, not a therapy.

Read more →

THYMALIN

A thymus-gland peptide bioregulator (Khavinson). The thymus, where T-cells mature, shrinks with age; Thymalin is used in short annual courses to support immune function and healthy aging. Different from Thymosin Alpha-1 (a single defined peptide); Thymalin is a thymic peptide complex.

Read more →

THYMOSIN ALPHA-1

An immune-system booster. Approved in 35+ countries (as Zadaxin) for chronic hepatitis. Not approved in the US.

Read more →

VESUGEN

A short peptide bioregulator (Khavinson) aimed at the vascular system, blood vessels. Part of the model that aging happens along three tracks (cellular, immune, vascular); Vesugen targets the vascular track in brief courses.

Read more →